| Morphological, physiological, and biochemical changes in rhodopsin knockout mice J Lem, NV Krasnoperova, PD Calvert, B Kosaras, DA Cameron, M Nicolo, ... Proceedings of the National Academy of Sciences 96 (2), 736-741, 1999 | 460 | 1999 |
| Phototransduction in transgenic mice after targeted deletion of the rod transducin α-subunit PD Calvert, NV Krasnoperova, AL Lyubarsky, T Isayama, M Nicolo, ... Proceedings of the National Academy of Sciences 97 (25), 13913-13918, 2000 | 399 | 2000 |
| Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double … JS Heier, AM Khanani, CQ Ruiz, K Basu, PJ Ferrone, C Brittain, ... The Lancet 399 (10326), 729-740, 2022 | 327 | 2022 |
| Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two … CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ... The Lancet 399 (10326), 741-755, 2022 | 278 | 2022 |
| Half-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathy M Nicoló, CM Eandi, C Alovisi, FM Grignolo, CE Traverso, D Musetti, ... American Journal of Ophthalmology 157 (5), 1033-1037. e2, 2014 | 150 | 2014 |
| Faricimab: an investigational agent targeting the Tie-2/angiopoietin pathway and VEGF-A for the treatment of retinal diseases M Nicolò, L Ferro Desideri, A Vagge, CE Traverso Expert opinion on investigational drugs 30 (3), 193-200, 2021 | 101 | 2021 |
| Choroidal vascular flow area in central serous chorioretinopathy using swept-source optical coherence tomography angiography M Nicolò, R Rosa, D Musetti, M Musolino, M Saccheggiani, CE Traverso Investigative ophthalmology & visual science 58 (4), 2002-2010, 2017 | 75 | 2017 |
| Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central … M Nicolò, D Zoli, M Musolino, CE Traverso Am J Ophthalmol 153 (3), 474-480, 2012 | 66 | 2012 |
| Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin) M Nicolo, D Ghiglione, G Calabria European journal of ophthalmology 16 (5), 770-773, 2006 | 64 | 2006 |
| Combining macula clinical signs and patient characteristics for age-related macular degeneration diagnosis: a machine learning approach P Fraccaro, M Nicolo, M Bonetto, M Giacomini, P Weller, CE Traverso, ... BMC ophthalmology 15, 1-9, 2015 | 58 | 2015 |
| Choroidal vascular reactivity in central serous chorioretinopathy FC Piccolino, M Lupidi, C Cagini, D Fruttini, M Nicolo, CM Eandi, S Tito Investigative Ophthalmology & Visual Science 59 (10), 3897-3905, 2018 | 51* | 2018 |
| Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin M NicolÒ, D Ghiglione, S Lai, F Nasciuti, S Cicinelli, G Calabria Retina 26 (1), 58-64, 2006 | 47 | 2006 |
| Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations L Kodjikian, M Parravano, A Clemens, R Dolz-Marco, FG Holz, MR Munk, ... Eye 35 (8), 2119-2135, 2021 | 40 | 2021 |
| Vascular endothelial growth factor-C secretion is increased by advanced glycation end-products: possible implication in ocular neovascularization A Puddu, R Sanguineti, A Durante, M Nicolò, GL Viviani Molecular vision 18, 2509, 2012 | 39 | 2012 |
| Retinal angiomatous proliferation treated by intravitreal triamcinolone and photodynamic therapy with verteporfin M Nicolò, D Ghiglione, S Lai, G Calabria Graefe's Archive for Clinical and Experimental Ophthalmology 244, 1336-1338, 2006 | 35 | 2006 |
| Clinical efficacy and safety of ranibizumab in the treatment of wet age-related macular degeneration L Ferro Desideri, F Barra, S Ferrero, CE Traverso, M Nicolò Expert opinion on biological therapy 19 (8), 735-751, 2019 | 34 | 2019 |
| Evaluation of choroidal thickness and choroidal vascular blood flow in patients with thyroid-associated orbitopathy (TAO) using SD-OCT and Angio-OCT C Del Noce, A Vagge, M Nicolò, CE Traverso Graefe's Archive for Clinical and Experimental Ophthalmology 258, 1103-1107, 2020 | 30 | 2020 |
| Ranibizumab for Visual Impairment due to Diabetic Macular Edema: Real‐World Evidence in the Italian Population (PRIDE Study) U Menchini, F Bandello, V De Angelis, F Ricci, L Bonavia, F Viola, ... Journal of ophthalmology 2015 (1), 324841, 2015 | 29 | 2015 |
| Intravitreal triamcinolone in the treatment of serous pigment epithelial detachment and occult choroidal neovascularization secondary to age-related macular degeneration M Nicolö, D Ghiglione, S Lai, G Calabria European journal of ophthalmology 15 (3), 415-419, 2005 | 28 | 2005 |
| The emerging role of the Angiopoietin-Tie pathway as therapeutic target for treating retinal diseases L Ferro Desideri, CE Traverso, M Nicolò Expert Opinion on Therapeutic Targets 26 (2), 145-154, 2022 | 27 | 2022 |
Mauro GiacominiProfessor of Bioengineering, University of Genoa在 dist.unige.it 的电子邮件经过验证
